Studies on the Concentration of Arsenic, Selenium, Copper, Zinc and Iron in the Blood of Blackfoot Disease Patients in Different Clinical Stages by Wang, C. T. et al.
Wang et al.: Trace elements in different stages of blackfoot disease 759
Eur. J. Clin. Chem. Clin. Biochem.
Vol. 31, 1993, pp. 759-763
© 1993 Walter de Gruyter & Co.
Berlin · New York
Studies on the Concentration of Arsenic, Selenium, Copper, Zinc and Iron
in the Blood of Blackfoot Disease Patients in Different Clinical Stages
By C. T. Wang1, C. W. Huang\ S. S. Chou2, D. T. Lin\ S. R. Liau3 and R. T. Wang4
1 Department of Chemistry, Chung-Yuan Christain University
2 National Laboratories of Food and Drugs Department of Health Executive Yuan
3 Taiwan Provincal Chi-Yi Hospital
4 Department of Food Sanitation, Ta-Jan Pharmaceutical College
Taiwan, Republic of China
(Received December 7, 1992/July 14, 1993)
Summary: Flame atomic absorption spectrophotometric methods were developed for the determination of
zinc, copper, arsenic, iron and selenium in blood samples. Data from blackfoot disease patients in five clinical
stages were compared with those from healthy controls. Copper concentrations were the same for all clinical
stages. Arsenic increased in the initial three stages but decreased thereafter, although arsenic was previously
considered to be the major causative agent of the disease. The decrease of arsenic in the later stages was
attributed to the antagonistic effect of selenium, and the decrease of iron during the progress of the disease
is thought to be due to the antagonistic effect of arsenic in the initial stages and the loose of haemoglobin in
the later stages.
Introduction
An endemic peripheral vascular disease called black-
foot disease is suffered by a large number of inhabi-
tants on the southwest coast of Taiwan (1 —6). The
disease has an insidious onset with numbness or cold-
ness as the initial symptom. It progresses with the
development of localized ulceration and subsequent
gangrenous changes, giving the characteristic black
coloration of dry gangrene. Most patients are per-
manently maimed as a result of spontaneous or arti-
ficial amputation of a portion of the affected extrem-
ity (7).
Blackfoot disease is thought to be related to the
presence in artesian drinking water of high concen-
trations of arsenic, silicate, copper, nickel and certain
fluorescent compounds, with arsenic as the primary
suspect (8-18).
Patients with advanced clinical symptoms should
therefore have a high concentration of blood arsenic,
but our preliminary results showed a decrease of
arsenic in the advanced stages. In order to assess this
situation, we determined arsenic, iron, selenium, zinc
and copper in blood samples from blackfoot disease
patients in different clinical stages. The results indicate




One hundred and thirteen blood samples of blackfoot disease
patients at five clinical stages according to the criteria set by
Drs. U. C. Huang and D. T. Lin (tab. 1), and 49 blood samples
of persons with no known history of exposure to arsenic were
used. As shown in table 2, there was an even distribution of
age and sex between the two groups. Samples were frozen below
-20°C until used.
Chemicals and biological s tandards
SuprapuT grade reagents of E. Merck and high purity water
(18 ΜΩ) were used. Stock solutions containing 1000 mg/1 or
mg/kg of iron, zinc, copper, seltenium and arsenic and working
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Tab. 1. The different stages of blackfoot disease as classified in
Chi-Yi hospital, Taiwan
Stage Symptom
Zero stage Assumed to be present in residents of endemic
area without evidence of disease.
First stage Coldness, numbness and pain.
Second stage Evidence of slight ulceration and slight gan-
grenous changes.
Third stage Evidence of definite ulceration and definite
gangrenous changes.
Fourth stage Evidence of gangrenous changes of the af-
fected extremity. Spontaneous or artifical am-
putation of foot.
Tab. 2. The distribution of specimens



























Note: The ages of the patients and healthy control persons
were about 65 + 10 years.
standard solutions were prepared from Merck Titrisol stan-
dards by diluting with the high purity water. Containers made
of quartz, Teflon, or polypropylene were used throughout. They
were immersed in 8mol/l HNO3 overnight and washed with
several changes of distilled water. Biological standards were
NIES human hair No. 5, and NBS serum 1598.
Analytical methods
Atomic absorption spectrophotometer model Z-8000 and its
accessory Hydride Formation System HFS-2 from Hitachi,
Japan were used for determining trace metals. Prolab Maxdiges-
ter 350 (France) was used for sample digestion.
To 10 ml of a whole blood in a digestion flask were added 20
ml of cone. HNO3. The power output of the digester was
maintained at 15% for 15 min and at 25% for 10 min. After
adding 7 ml each of cone. H2SO4 and HC1O4, the digestion was
continued at 30% power for 10 min and at 40% for 35 min.
Finally 10 ml of water was added and the power kept at 40%
until a colourless solution was obtained (taking about 8 min).
The digest was diluted to 50 ml with the high purity water.
Aliquots were taken for the ordinary (iron, zinc and copper)
and the hydride (arsenic and selenium) modes of atomic ab-
sorption spectrophotometer.
Results and Discussion , *·..
Data accuracy and analyte recovery
To check the data quality, human serum and hair
standards were analysed. As shown in table 3a, the
best accuracy, expressed as the % coefficient of var-



































* HFAA: Hydride flame atomic absorption.
** FAA: Flame atomic absorption.



































* HFAA: Hydride flame atomic absorption.
** FAA: Flame atomic absorption.
*** N.I.E.S. National Institute for Environmental Studies (Japan-Environment Agency)
**** N. I. E. S. No. 5 Human hair reference value.
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iation (CV%) and recovery of analytes from the serum
standard, were less than 8.4% and 98% for copper,
less than 4.6% and 96% for zinc, and less than 3.7%
and 95% for iron, respectively. Selenium, however,
had a larger CV% of 11.1 and a poor recovery of
84%, owing to its volatility. The results in table 3b
indicated that the best accuracy (CV%) and recovery
of analyses of the human hair standard were less than
6.0% and 100% for iron, less than 5.4% and 97%
for zinc, and less than 4.5% and 95% for copper,
respectively. Again, selenium had a high CV (21.7%)
and a poor recovery (83%). The recoveries of arsenic
added to whole blood of normal persons and black-
foot disease patients in the first clinical stage are
compared in table 4. Patient samples showed a higher
CV (14.1%) and a higher recovery (86.5%) than sam-
ples from controls (13.5% and 84.7%, respectively).
Recovery and standard curves
Standard and recovery curves of iron, zinc, copper,
selenium and arsenic were obtained by analysing nor-
mal blood samples. To 1 ml of the sample were added
the following:
0.4, 1, 2, 4, and 10 μg of iron;
0.2, 0.4, 1 and 2 μg of zinc and copper;
2, 4, 10 and 20 ng of selenium;
2, 4, 10 and 20 ng of arsenic.
The results are shown in figures 1 and 2. Good linear
relationships were obtained for these concentration
ranges. Good recoveries of 97, 95 and 91% were
obtained for iron, zinc and copper, respectively.
Poorer recoveries of 81 and 87% were obtained for
arsenic and selenium, respectively, owing to their vol-
atility.
Tab. 4. Recoveries of arsenic added to whole blood of normal persons and blackfoot disease patients in the first stage of the
disease (n = 6)
Whole blood from No.
Specimens

















Amount of Fe, Cu and Zn added [μηιοΙ/Ι]
Fig. 1. Assay curves for iron, copper and zinc.
Δ Fe in purified water A Fe in normal person blood
D Cu in purified water · Cu in normal person blood
ο Zn in purified water · Zn in normal person blood
150
Amount of As and Se added [nmol/l]
300
Fig. 2. Standard curves for the assay of arsenic and selenium.
Δ As in purified water A As in normal person blood
π Se in purified water · Se in normal person blood
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Analyses of blood samples
Table 5 shews the analytical results of blood samples
obtained from the normal and diseased persons with-
out discrimination of clinical stages. It shows that the
blood zinc and copper concentrations of patients do
not differ from those of normal individuals; they fall
within the 5% deviation (zinc, 64.3 ± 21.4 and 62.5
± 19.5 μιηοΐ/ΐ; copper, 9.44 ± 4.09 and 9.11 ± 3.99
μιηοΐ/ΐ), but arsenic, selenium and iron showed sig-
nificant differences, with deviations of 49, 25 and
17%, respectively (arsenic, 89.4 ± 45.3 and 133.4
± 72.0 nmol/1; selenium, 0.79 ± 0.28 and 0.59 ±
0.30 μιηοΐ/l; iron, 9.88 ± 1.66 and 11.5 ± 3.24
μιηοΐ/ΐ). Patient blood samples contained lower sele-
nium concentrations, but higher arsenic and iron con-
centrations than those of controls. Blood arsenic con-
centrations of patients in different clinical stages and
living in higher endemic areas were compared with




















Samples from patients in higher endemic areas had a
significantly higher arsenic value of 10.5 ± 5.6 μg/l
compared with 7.7 ±4.3 μg/l in the lower endemic
areas, with a deviation of 26%. A positive correlation
therefore exists between the blood arsenic concentra-
tion and the onset of blaekfoot disease.
Antagonism of arsenic by selenium
Figure 3 shows the analytical results of blood speci-
mens obtained from patients in different clinical
stages. It shows that the deviation of blood copper,
zinc and iron for either diseased or normal persons
were always within + 5%. But arsenic and selenium
had a larger deviation of more than + 10%. The
copper concentrations for either patients or normal





Tab. 6. Comparisons of blood arsenic concentrations of black- E









Fig. 3. Blood arsenic, selenium, iron, copper and zinc concen-
trations in different stages of blaekfoot disease. Each
value has been divided by the. denominator shown, e. g.
the values for As have been Divided by 100.
Δ (As/100) · (Se/1000) A (Fe/10)
o (Cu/10) D (Zn/100)
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Therefore blood copper seems to have little or no
effect on blood arsenic.
Selenium seems to have a relatively large antagonistic
effect on blood arsenic; as the clinical stages pro-
gressed from zero to stage 2, the blood arsenic in-
creased significantly from 0.08 to 0.16 μτηοΐ/ΐ and
selenium from 0.71 to 0.56 μπιοΐ/ΐ. At the third and
fourth stages, the level of selenium is maintained at
about 0.50 μιηοΐ/ΐ, exerting a continual antagonistic
effect which causes the blood arsenic to decrease to
0.11 μιηοΐ/ΐ. This would explain some reports that
blackfoot disease patients have lower blood arsenic
values, whereas most reports emphasize arsenic as a
major causative agent of the disease based on the
results of drinking water analyses. This antagonistic
effect is not only of academic interest and worthy of
further study, but also important in the clinical treat-
ment of blackfoot disease patients.
The blood iron contents of patients decreased as the
clinical stages progressed from zero to stage 4, with
values changing from 10.9 to 9.04 mmol/1. Two rea-
sons may be offered for the decrease: 1. the antago-
nistic effect of arsenic toward iron, and 2. the loss of
haemoglobin. The iron status of the patients is also
worthy of further study from both the academic and
clinical points of view.
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